Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype

Menée in vitro et in vivo sur des modèles de médulloblastome, cette étude met en évidence des mécanismes liés à la barrière hémato-encéphalique et permettant de rendre compte de la différence d'efficacité des chimiothérapies selon le sous-type de la maladie (WNT ou SHH)

Résumé en anglais

The childhood brain tumor, medulloblastoma, includes four subtypes with very different prognoses. Here, we show that paracrine signals driven by mutant ?-catenin in WNT-medulloblastoma, an essentially curable form of the disease, induce an aberrant fenestrated vasculature that permits the accumulation of high levels of intra-tumoral chemotherapy and a robust therapeutic response. In contrast, SHH-medulloblastoma, a less curable disease subtype, contains an intact blood brain barrier, rendering this tumor impermeable and resistant to chemotherapy. The medulloblastoma-endothelial cell paracrine axis can be manipulated in vivo, altering chemotherapy permeability and clinical response. Thus, medulloblastoma genotype dictates tumor vessel phenotype, explaining in part the disparate prognoses among medulloblastoma subtypes and suggesting an approach to enhance the chemoresponsiveness of other brain tumors.